Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes
Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes
复制标题
DOI:
10.1016/j.bcp.2006.01.015
复制
发表时间:
2006-04-28
影响因子:
5.8
通讯作者:
Hanioka, N
中科院分区:
文献类型:
--
作者:
Narimatsu, S;Yonemoto, R;Hanioka, N
In vitro quantitative studies of the oxidative metabolism of (S-methoxy-N,N-diisopropyl-tryptamine, 5-MeO-DIPT, Foxy) were performed using human liver microsomal fractions and recombinant CYP enzymes and synthetic 5-MeO-DIPT metabolites. 5-MeO-DIPT was mainly oxidized to O-demethylated (5-OH-DIPT) and N-deisopropylated (S-MeO-IPT) metabolites in pooled human liver microsomes. In kinetic studies, 5-MeO-DIPT O-demethylation showed monophasic kinetics, whereas its N-deisopropylation showed triphasic kinetics. Among six recombinant CYP enzymes (CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) expressed in yeast or insect cells, only CYP2D6 exhibited 5-MeO-DIPT O-demethylase activity, while CYP1A2, CYP2C8, CYP2C9, CYP2C19 and CYP3A4 showed 5-MeO-DIPT N-deisopropylase activities. The apparent K, value of CYP2D6 was close to that for 5-MeO-D1PT O-demethylation, and the K-m values of other CYP enzymes were similar to those of the low-Km (CYP2C19), intermediate-K-m (CYP1A2, CYP2C8 and CYP3A4) and high-K-m phases (CYP2C9), respectively, for N-deisopropylation in human liver microsomes. in inhibition studies, quinidine (1 mu M), an inhibitor of CYP2D6, almost completely inhibited human liver microsomal 5-MeO-DIPT O-demethylation at a substrate concentration of 10 mu M.